NARI - Inari Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
44.00
+1.25 (+2.92%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close42.75
Open43.00
Bid44.40 x 3200
Ask44.78 x 800
Day's Range42.11 - 45.50
52 Week Range39.55 - 47.89
Volume788,122
Avg. Volume1,936,460
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Inari Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

    The gross proceeds to Inari, before deducting underwriting discounts and commissions and offering expenses, were approximately $179.2 million. Inari’s common stock is listed on the Nasdaq Global Select Market under the symbol "NARI."

  • Inari Medical shares soar in IPO
    Yahoo Finance Video

    Inari Medical shares soar in IPO

    Inari Medical shares soar in public debut under the ticker NARI. Yahoo Finance's Adam Shapiro discusses.

  • MarketWatch

    Inari Medical's stock blasts off, trades more than double the IPO price

    Shares of Inari Medical Inc. rocketed out of the gate Friday, as they opened for trading at prices that were more than double the initial public offering price. The Irvine, Calif.-based company, which develops medical devices for patients suffering from venous diseases, upsized its IPO to 8.20 million shares from 7.33 million shares. The company raised $155.85 million in the IPO, which priced at $19, above the expected range of $17 to $18, which was recently raised from $14 to $16. The stock's first trade was at $41.30--117% above the IPO price--at 12:09 p.m. ET for 1.1 million shares. It has since held its gains, and was most recently up 116%. The company went public at a time that the Renaissance IPO ETF has gained 2.9% over the past three months, while the S&P 500 has lost 12.0%.

  • MarketWatch

    Inari Medical increases shares it sold in IPO, which priced above the expected range

    Inari Medical Inc. increased that number of shares it was selling in its initial public offering, which priced late Thursday above the expected range. The Irvine, Calif.-based company, which develops medical devices for patients suffering from venous diseases, offered 8.2 million shares in the IPO, up from 7.33 million. The IPO priced at $19 a share, above the expected range of $17 to $18 a share, which was raised early Thursday from a previous expected range of $14 to $16. The company raised $155.85 million in the IPO. The stock is expected to begin trading on the Nasdaq exchange Friday. BofA Securities and Morgan Stanley are the joint lead bookrunning managers for the offering. The company is going public at a time that the Renaissance IPO ETF has gained 2.2% over the past three months while the S&P 500 has lost 11.7%.

  • GlobeNewswire

    Inari Medical Announces Pricing of Its Upsized Initial Public Offering

    All of the shares are being offered and sold by Inari. In addition, Inari has granted the underwriters a 30-day option to purchase up to an additional 1,230,384 shares of common stock at the initial public offering price, less underwriting discounts and commissions.